FindTrial
Sign In

N-Acetylneuraminic Acid

6 trials

Sponsors

Center of Molecular Immunology(CIM), Center of Molecular Immunology (CIM), Center for Genetic Engineering and Biotechnology (CIGB), in Havana.

Conditions

Acquired immunodeficiency syndrome (AIDS)Breast cancer IIa, IIb and IIIa surgically treated with positive gangliaCancer of ovary, fallopian tubes and / or peritoneum.HIV/AIDSHepatocellular carcinomaMetastatic Breast Cancer

Phase 2

NGcGM3/VSSP/Montanide ISA 51 vaccine in metastatic breast cancer. Phase II
Active, not recruitingRPCEC00000068
Center of Molecular Immunology (CIM)Metastatic Breast Cancer
Start: 2002-08-27Target: 80Updated: 2026-03-30
NAcGM3/VSSP/Montanide ISA 51 formulation in HIV, phase II.
RecruitingRPCEC00000015
Center of Molecular Immunology(CIM)HIV/AIDS
Start: 2008-02-21Target: 118Updated: 2026-03-30
NAcGM3/VSSP-aids-patients drug resistant to antiretroviral treatment-Phase I-II
Active, not recruitingRPCEC00000213
Center of Molecular Immunology (CIM)Acquired immunodeficiency syndrome (AIDS)
Start: 2015-01-28Target: 25Updated: 2026-03-30
CENTAURO-6 Study
Active, not recruitingRPCEC00000237
Center for Genetic Engineering and Biotechnology (CIGB), in Havana.Hepatocellular carcinoma
Start: 2017-04-03Target: 20Updated: 2026-03-30

Phase 3

NGcGM3/VSSP/Montanide ISA 51 vaccine for breast cancer IIa, IIb and IIIa surgically treated with positive ganglia and disease-free, Phase IIb/III.
RecruitingRPCEC00000070
Center of Molecular Immunology (CIM)Breast cancer IIa, IIb and IIIa surgically treated with positive ganglia
Start: 2007-04-17Target: 744Updated: 2026-03-30
CENTAURO-4 Study
Active, not recruitingRPCEC00000246
Center for Genetic Engineering and Biotechnology (CIGB), in Havana.Cancer of ovary, fallopian tubes and / or peritoneum.
Start: 2017-05-02Target: 40Updated: 2026-03-30